207 related articles for article (PubMed ID: 38040034)
1. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
[TBL] [Abstract][Full Text] [Related]
2. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
[TBL] [Abstract][Full Text] [Related]
3. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
Cleaver JE
J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition.
Matakidou A; Eisen T; Fleischmann C; Bridle H; Houlston RS;
Int J Cancer; 2006 Aug; 119(4):964-7. PubMed ID: 16550608
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
Yamashita T; Okura M; Ishii-Osai Y; Hida T
J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
[TBL] [Abstract][Full Text] [Related]
6. Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.
Fu L; Xu X; Ren R; Wu J; Zhang W; Yang J; Ren X; Wang S; Zhao Y; Sun L; Yu Y; Wang Z; Yang Z; Yuan Y; Qiao J; Izpisua Belmonte JC; Qu J; Liu GH
Protein Cell; 2016 Mar; 7(3):210-21. PubMed ID: 26874523
[TBL] [Abstract][Full Text] [Related]
7. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
9. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
Lehmann AR
Biochimie; 2003 Nov; 85(11):1101-11. PubMed ID: 14726016
[TBL] [Abstract][Full Text] [Related]
10. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
Lehmann AR; Fassihi H
DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
15. Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UV-induced DNA damage.
Oh KS; Imoto K; Boyle J; Khan SG; Kraemer KH
DNA Repair (Amst); 2007 Sep; 6(9):1359-70. PubMed ID: 17509950
[TBL] [Abstract][Full Text] [Related]
16. First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP-C founder mutation.
Khalat N; Messaoud O; Ben Rekaya M; Chargui M; Zghal M; Zendah B; Saqer N; Mokni M; Abdelhak S; Mohamed OA
Mol Genet Genomic Med; 2023 Jun; 11(6):e2158. PubMed ID: 36812379
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive germline mutation analysis and clinical profile in a large cohort of Brazilian xeroderma pigmentosum patients.
Santiago KM; Castro LP; Neto JPD; de Nóbrega AF; Pinto CAL; Ashton-Prolla P; Pinto E Vairo F; de Medeiros PFV; Ribeiro EM; Ribeiro BFR; do Valle FF; Doriqui MJR; Leite CHB; Rocha RM; Moura LMS; Munford V; Galante PAF; Menck CFM; Rogatto SR; Achatz MI
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2392-2401. PubMed ID: 32239545
[TBL] [Abstract][Full Text] [Related]
18. Lack of CAK complex accumulation at DNA damage sites in XP-B and XP-B/CS fibroblasts reveals differential regulation of CAK anchoring to core TFIIH by XPB and XPD helicases during nucleotide excision repair.
Zhu Q; Wani G; Sharma N; Wani A
DNA Repair (Amst); 2012 Dec; 11(12):942-50. PubMed ID: 23083890
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]